These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 7954394

  • 1. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
    Silletti S, Timar J, Honn KV, Raz A.
    Cancer Res; 1994 Nov 15; 54(22):5752-6. PubMed ID: 7954394
    [Abstract] [Full Text] [Related]

  • 2. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
    Timar J, Silletti S, Bazaz R, Raz A, Honn KV.
    Int J Cancer; 1993 Dec 02; 55(6):1003-10. PubMed ID: 8253518
    [Abstract] [Full Text] [Related]

  • 3. Suppression of melanoma cell motility factor receptor expression by retinoic acid.
    Lotan R, Amos B, Watanabe H, Raz A.
    Cancer Res; 1992 Sep 15; 52(18):4878-84. PubMed ID: 1325286
    [Abstract] [Full Text] [Related]

  • 4. Multiple use of a signal transduction pathway in tumor cell invasion.
    Tímár J, Rásó E, Fazakas ZS, Silletti S, Raz A, Honn KV.
    Anticancer Res; 1996 Sep 15; 16(6A):3299-306. PubMed ID: 9042304
    [Abstract] [Full Text] [Related]

  • 5. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
    Silletti S, Yao JP, Pienta KJ, Raz A.
    Int J Cancer; 1995 Sep 27; 63(1):100-5. PubMed ID: 7558435
    [Abstract] [Full Text] [Related]

  • 6. [The role of autocrine motility factor receptor in metastasis].
    Watanabe H, Chigira M, Raz A.
    Gan To Kagaku Ryoho; 1993 Feb 27; 20(3):405-9. PubMed ID: 8382466
    [Abstract] [Full Text] [Related]

  • 7. Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
    Kojic LD, Wiseman SM, Ghaidi F, Joshi B, Nedev H, Saragovi HU, Nabi IR.
    PLoS One; 2008 Feb 27; 3(10):e3597. PubMed ID: 18974847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis.
    Chen YQ, Duniec ZM, Liu B, Hagmann W, Gao X, Shimoji K, Marnett LJ, Johnson CR, Honn KV.
    Cancer Res; 1994 Mar 15; 54(6):1574-9. PubMed ID: 7511046
    [Abstract] [Full Text] [Related]

  • 13. Enhancement role of host 12/15-lipoxygenase in melanoma progression.
    Kang KH, Ling TY, Liou HH, Huang YK, Hour MJ, Liou HC, Fu WM.
    Eur J Cancer; 2013 Aug 15; 49(12):2747-59. PubMed ID: 23664097
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
    Honn KV, Tang DG, Grossi I, Duniec ZM, Timar J, Renaud C, Leithauser M, Blair I, Johnson CR, Diglio CA.
    Cancer Res; 1994 Jan 15; 54(2):565-74. PubMed ID: 8275495
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.